A Study in Healthy Men to Find the Best Formulation for Once Daily Intake of Nintedanib
Clinical trial NCT05262751 · COMPLETED
Trial details
- NCT number
- NCT05262751
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2022-11-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.